Knowledge base
Archived articles from Synergus RWE, kept for reference.
3 articles
Class IIb and III – Clarify Eligibility for 137 (h) prior to submitting NUB in Germany!
In a recent post by G-BA, they reinforced to the hospitals are required to submit a 137(h) application for medical devices of class IIb or III, unless G-BA already has clarified that the product is not eligible. It is…
GermanyCoverage with Evidence DevelopmentMedical Device
France: Temporary reimbursement pending results from clinical trial
France offers a pathway called PECT (The Prise en Charge Transitoire ) for temporary reimbursement off valuable and innovative medical devices and services pending completion of ongoing clinical trial. The aim is to…
FranceCoverage with Evidence DevelopmentMedical Device
The German NUB process, the most risky process for a start-up?
For many medical device companies, the German NUB process to fund innovative medical devices used in the hospitals, has been known as the most attractive option for a European launch. This is a brief overview of how the…
GermanyCoverage with Evidence DevelopmentInnovation Funding